Mark C. Eagleton
Washington University in St. Louis(US)
Publications by Year
Research Areas
Bone health and treatments, Bone Metabolism and Diseases, Inflammatory mediators and NSAID effects, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling(2012)101 cited
- → Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner(2006)93 cited
- → The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts(2009)63 cited
- → APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice(2008)58 cited
- → Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone(2007)54 cited
- → Interferon-γ Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases(2008)45 cited
- → The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice(2010)26 cited
- → P7. The ADP receptor P2Y12 is expressed in developing osteoclasts and is required for full osteoclast function and tumor associated osteolysis(2008)2 cited